ADMA - Company ID 0001368514
The table below shows ADMA BIOLOGICS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $124.56M | $136.02M | $138.15M | $61.38M | $90.28M | $71.63M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $169.22M | $138.23M | $135.86M | $137.67M | $109.73M | $99.41M |
| Inventory | $266.12M | $239.31M | $222.10M | $196.67M | $191.46M | $172.19M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $575.86M |
| $528.20M |
| $511.17M |
| $402.65M |
| $399.56M |
| $351.81M |
| Property, plant & equipment | $66.76M | $66.66M | $65.01M | $69.51M | $57.50M | $57.71M |
| Goodwill | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M |
| Total assets | $732.49M | $684.21M | $665.18M | $568.69M | $558.38M | $510.57M |
| Accounts payable | $35.66M | $31.72M | $20.52M | $24.02M | $29.77M | $20.61M |
| Total current liabilities | $95.28M | $75.76M | $73.54M | $56.49M | $74.94M | $53.50M |
| Long-term debt | $191.64M | $192.84M | $193.58M | $70.08M | - | - |
| Total liabilities | $293.98M | $276.00M | $274.86M | $137.50M | $160.06M | $137.15M |
| Retained earnings | -$28.62M | -$78.50M | -$116.33M | -$211.03M | -$247.46M | -$281.68M |
| Total equity | $438.51M | $408.21M | $390.32M | $431.19M | $398.32M | $373.42M |